🇺🇸 FDA
Patent

US 7687506

Selective serine/threonine kinase inhibitors

granted A61PA61P35/00

Quick answer

US patent 7687506 (Selective serine/threonine kinase inhibitors) held by The Regents of the University of California expires Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
33
CPC classes
A61P, A61P35/00